Caplin Point Laboratories quarterly results and financials

Caplin Point Laboratories (CAPLIPOINT)₹2,503+1.84%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Caplin Point Laboratories reported sales of ₹610 Cr, up 19.6% from Jun 2025, and net profit of ₹179 Cr, up 18.5% year on year. For the year to Mar 2026, sales were ₹2,186 Cr and net profit ₹651 Cr.

Sales (Jun 2026): ₹610 Cr
Net profit (Jun 2026): ₹179 Cr
Sales (FY Mar 2026): ₹2,186 Cr
Net profit (FY Mar 2026): ₹651 Cr
EPS (Jun 2026): ₹23.19
Borrowings (Mar 2026): ₹4.99 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Caplin Point Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Caplin Point Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	410	436	453	459	483	493	502	510	534	543	600	610
Expenses	272	292	307	306	317	330	333	331	344	352	394	396
Operating Profit	137	142	145	152	165	163	169	178	190	191	204	214
OPM %	34.1%	33.1%	32.1%	33.1%	34.1%	33.1%	33.1%	35.1%	35.1%	35.1%	34.1%	35.1%
Other Income	21.09	17.05	17.05	19.06	21.08	31.09	26.08	23.10	30.11	34.14	28.10	34.10
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	11.96	13.93	15.95	15.95	16.93	15.93	16.93	15.95	17.93	18.94	18.91	21.91
Profit before tax	147	146	146	155	169	178	178	185	202	205	214	226
Tax %	19.9%	18.0%	16.9%	18.9%	21.9%	20.9%	17.9%	17.9%	19.9%	19.0%	18.9%	19.9%
Net Profit	116	120	121	125	131	140	145	151	160	166	173	179
EPS (Rs)	15.09	15.37	15.96	16.26	17.15	18.22	18.69	20.02	20.25	21.48	22.30	23.19

Caplin Point Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Caplin Point Laboratories Profit and loss
	Mar 2016 9m	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	239	402	540	649	863	1,061	1,270	1,467	1,695	1,938	2,186	2,287
Expenses	174	275	344	415	601	729	871	1,021	1,138	1,283	1,420	1,486
Operating Profit	64.13	125	196	233	261	330	396	443	553	653	763	798
OPM %	27.1%	31.1%	36.1%	36.1%	30.1%	31.1%	31.1%	30.1%	33.1%	34.1%	35.1%	34.9%
Other Income	4.02	10.03	13.04	19.07	41.13	23.08	38.10	55.17	66.18	92.30	116	126
Interest	0.00	0.99	0.99	0.99	0.00	1.99	0.99	0.99	0.99	0.99	0.99	0.00
Depreciation	6.98	12.96	18.93	22.92	31.87	36.88	46.78	44.79	52.83	65.73	72.66	77.69
Profit before tax	60.19	122	189	228	270	315	388	452	566	679	806	846
Tax %	23.9%	20.9%	22.9%	22.0%	19.9%	19.9%	20.0%	15.9%	17.9%	19.9%	18.9%	—
Exceptional items	0.00	0.00	1.01	1.01	4.01	4.01	1.01	1.01	1.01	0.00	0.00	—
Net Profit	46.10	96.17	145	177	215	252	309	378	462	542	651	679
EPS (Rs)	6.03	12.61	19.10	23.26	28.32	31.92	39.43	49.38	60.00	70.29	84.07	87.22
Dividend payout %	20.0%	12.0%	10.0%	9.0%	9.0%	9.0%	10.0%	9.0%	8.0%	8.0%	5.0%	—

Caplin Point Laboratories balance sheet

₹ crore, at each year end.

Caplin Point Laboratories Balance sheet
	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	15.06	15.06	15.07	15.05	15.06	15.06	15.06	15.07	15.04	15.06	15.07	15.05
Reserves	78.18	113	210	350	583	859	956	1,256	1,652	2,089	2,625	3,578
Borrowings	1.99	1.99	0.99	0.99	35.92	113	235	219	222	219	222	4.99
Other Liabilities	134	137	133	136	109	139	160	249	304	378	350	452
Total Liabilities	230	268	359	501	744	1,128	1,366	1,738	2,192	2,701	3,212	4,050
Fixed Assets	113	144	153	170	228	273	306	288	281	455	548	607
CWIP	30.94	0.00	2.99	14.95	9.98	19.94	13.96	17.97	220	117	144	208
Investments	0.00	0.00	17.01	47.03	70.04	61.08	11.01	89.11	281	376	590	860
Other Assets	85.08	122	186	269	437	772	1,034	1,344	1,411	1,754	1,931	2,376
Inventories	13.99	19.01	21.99	28.01	37.02	238	179	227	288	363	336	429
Trade receivables	6.01	7.99	32.99	126	160	229	279	317	394	543	632	826
Cash & equivalents	45.03	68.11	93.12	79.10	153	223	439	464	494	554	591	622
Total Assets	230	268	359	501	744	1,128	1,366	1,738	2,192	2,701	3,212	4,050

Caplin Point Laboratories cash flow

₹ crore, for each year.

Caplin Point Laboratories Cash flow
	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	49.86	41.90	67.78	65.81	82.80	44.91	268	336	270	317	431	522
Cash from investing activity	−22.94	−5.99	−35.91	−68.80	−99.83	−53.90	−29.95	−376	−216	−319	−332	−581
Cash from financing activity	−9.03	−14.05	−7.03	−12.04	90.26	80.23	−24.08	−41.15	−28.12	−38.11	−38.16	−46.18
Net cash flow	19.04	23.05	25.05	−14.02	73.19	70.16	215	−81.15	27.04	−39.07	61.08	−106
Capex	25.07	8.02	26.08	49.19	65.24	77.22	73.24	91.26	194	146	193	249
Free cash flow	24.02	34.01	43.05	17.99	18.01	−31.99	195	246	78.04	173	241	275
CFO / OP %	103.0%	92.0%	72.9%	53.0%	54.0%	38.0%	102.0%	106.0%	81.0%	77.0%	86.0%	88.0%

Caplin Point Laboratories ratios

Working-capital days and returns, by year.

Caplin Point Laboratories Ratios
	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	7	11	29	84	89	96	95	90	97	116	118	137
Inventory days	37	57	44	44	47	210	139	149	159	183	159	181
Days payable	112	168	155	144	76	57	68	102	84	116	103	125
Cash conversion cycle	−67	−99	−81	−16	61	251	166	138	173	184	175	194
Working capital days	−127	−113	−28	48	105	168	146	166	145	167	175	264
ROCE %	68.0%	62.1%	68.0%	63.0%	45.0%	33.0%	28.0%	28.1%	26.0%	26.0%	26.0%	25.1%

Caplin Point Laboratories: frequently asked questions

What are the latest quarterly results of Caplin Point Laboratories?

For the Jun 2026 quarter, Caplin Point Laboratories reported sales of ₹610 Cr, up 19.6% year on year and net profit of ₹179 Cr, up 18.5% year on year. The operating margin was 35.1%.

What is the annual revenue of Caplin Point Laboratories?

Caplin Point Laboratories' sales for the year to Mar 2026 were ₹2,186 Cr; over the last twelve months they were ₹2,287 Cr.

What is the net profit of Caplin Point Laboratories?

Net profit for the year to Mar 2026 was ₹651 Cr, and ₹679 Cr over the last twelve months. Earnings per share over the same trailing period were ₹87.22.

How much debt does Caplin Point Laboratories have?

Caplin Point Laboratories reported borrowings of ₹4.99 Cr at Mar 2026, against cash and equivalents of ₹622 Cr.

What is the free cash flow of Caplin Point Laboratories?

Cash from operations was ₹522 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹275 Cr.

Loading…